Abstract
Arterial stiffness is an independent predictor of cardiovascular events in a hypertensive population. Serum levels of matrix metalloproteinase (MMP)-9 are associated with arterial stiffness and predict cardiovascular risk. We investigated the role of MMP-9 polymorphism −1562C>T on blood pressure (BP) and arterial stiffness in a newly diagnosed hypertensive population. Untreated hypertensive patients (n=215, mean age 46±13 years) were studied. Supine BP, carotid-femoral pulse wave velocity (PWV) and augmentation index were assessed. Serum biochemistry and plasma MMP-9 concentrations were measured and genotyping performed following extraction of genomic DNA. BP, aortic PWV and serum MMP-9 levels were significantly higher in T-allele carriers of the −1562C>T polymorphism with a significant gene–dose effect (P<0.0001). In a stepwise regression model adjusting for known or likely determinants, the 1562C>T polymorphism emerged as an independent predictor of systolic BP (R2=0.25, P<0.0001), diastolic BP (R2=0.16, P<0.0001) and PWV (R2=0.47,P<0.0001). This is the first study to show the effect of MMP-9 polymorphism on BP and aortic stiffness in a hypertensive population. These results suggest that hypertensive patients carrying the T allele may be at increased risk of cardiovascular events.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension. Lancet 2005; 365: 217–223.
Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664–670.
Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241.
Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1–4.
Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10–15.
Spinale FG . Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002; 90: 520–530.
Noji Y, Kajinami K, Kawashiri MA, Todo Y, Horita T, Nohara A et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 2001; 39: 380–384.
Longo GM, Xiong W, Griener TC, Zhao Y, Fiotti N, Baxter BT . Matrix metalloproteinase 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625–632.
Zhang B, Ye S, Hermann SM, Erikssson P, de Matt M, Evans A et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788–1794.
Derosa G, D'Angelo A, Ciccarelli L, Piccini MN, Pricolo F, Salvadeo S et al. Matrix metalloproteinase-2, and 9 and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 2006; 13: 227–231.
Marx N, Frolich JC, Siam L, Ittner J, Wierse G, Schmidt A et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2003; 23: 283–288.
Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579–1585.
Yasmin, Wallace S, McEniery CM, Dakham Z, Pusalkar P, Mak-Petaja K et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscl Thromb Vasc Biol 2005; 25: 372.
Morgan AR, Zhang B, Tapper W, Collins A, Ye S . Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 2003; 81: 321–326.
Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA . Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscl Thromb Vasc Biol 2004; 24: 1479–1484.
Yasmin, McEniery C, O'Shaughnessy KM, Harnett P, Arshad A, Wallace S et al. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals. Arterioscl Thromb Vasc Biol 2006; 26: 1799–1805.
Mahmud A, Feely J . Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005; 46: 1118–1122.
Julius S, Shawna N . Sympathetic overactivity in hypertension. Am J Hypertens 1996; 9: 113S–120S.
Laurent S, Boutouyrie P, Lacolley P . Structural and genetic bases of arterial stiffness. Hypertension 2006; 45: 1050–1055.
McNulty M, Mahmud A, Spiers J, Feely J . Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects. J Hum Hypertens 2006; 20: 867–873.
Galis ZS, Johnson C, Godin D, Magid R, Shipley MJ, Senior RM et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002; 91: 852–859.
Skalska A, Gasowski J, Cwynar M . The relationship between pulse wave velocity and indexes of collagen synthesis in hypertensive patients, according to the level of systolic blood pressure. J Hum Hypertens 2005; 19: 731–735.
Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson JH et al. Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature 1994; 30: 555–557.
Schonbeck U, Mach F, Libby P . Generation of biologically active IL-1b by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1b processing. J Immunol 1998; 161: 3340–3346.
Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ . Vasoactive drugs influence aortic augmentation index independently of pulse wave velocity in healthy men. Hypertension 2001; 37: 1429–1433.
Mahmud A, Feely J . Adiponectin and arterial stiffness. Am J Hypertens 2005; 18: 1543–1548.
Cowley Jr AW . The genetic dissection of essential hypertension. Nat Genet 2006; 7: 829–840.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, S., Feely, J., Spiers, J. et al. Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens 21, 861–867 (2007). https://doi.org/10.1038/sj.jhh.1002244
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002244
Keywords
This article is cited by
-
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
BMC Cardiovascular Disorders (2021)
-
Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness
Neurological Sciences (2016)
-
Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?
Cytotechnology (2015)
-
Genetic Determinants of Arterial Stiffness
Journal of Cardiovascular Translational Research (2015)
-
Effects of N-Acetylcysteine on the Cardiac Remodeling Biomarkers and Major Adverse Events Following Acute Myocardial Infarction: A Randomized Clinical Trial
American Journal of Cardiovascular Drugs (2014)